NASDAQ
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a market cap of $530.21M as of Friday, May 22, 2026. The CTNM market cap is up 32.56% over the past 30 days and has grown 424.20% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.